Abstract:Aim MicroRNAs (miRNAs) regulate β‐cell function, and β‐cell mitochondria and insulin secretion are perturbed in diabetes. We aimed to identify key miRNAs regulating β‐cell mitochondrial metabolism and novel β‐cell miRNA‐mitochondrial pathways. Methods TargetScan (http://www.targetscan.org/) was used to predict if 16 miRNAs implicated in β‐cell function target 27 cis‐eGenes implicated in mitochondrial activity. The expression of candidate miRNAs and insulin secretion after 24 and 1 h pre‐incubation in 2.8, 11.1‐ and 16.7‐mM glucose was measured in clonal INS‐1 832/13 β‐cells. MiR‐29 silenced INS‐1 832/13 cells were assessed for insulin secretion (glucose, pyruvate, and K+), target cis‐eGene expression (Ndufv3 and Ndufa10 components of mitochondrial complex I (CI)), OXPHOS (CI‐V) protein expression, and mitochondrial OXPHOS respiration/activity. The expression of differentially expressed miR‐29 miRNAs was evaluated in Goto‐Kakizaki (GK) rat, db/db mouse and type 2 diabetic (T2D) human islets, as well as NMRI mouse islets cultured under glucolipotoxic conditions. Results MiR‐29, miR‐15 and miR‐124 were predicted to regulate ~20 cis‐eGenes, while miR‐29 alone was predicted to regulate ≥12 of these in rat and human species. MiR‐29 expression and insulin secretion were reduced in INS‐1 832/13 cells after 24 h in elevated glucose. MiR‐29 knockdown increased all tested insulin secretory responses, Nudfv3, Ndufa10, complex I and II expression, and cellular mitochondrial OXPHOS. MiR‐29 expression was reduced in db/db islets but increased in GK rat and T2D human islets. Conclusion We conclude miR‐29 is a key miRNA in regulating β‐cell mitochondrial metabolism and insulin secretion via underlying miR‐29‐OXPHOS complex pathways. Furthermore, we infer reduced miR‐29 expression compensatorily enhances insulin secretion under glucotoxicity.

MicroRNA 29 modulates β‐cell mitochondrial metabolism and insulin secretion via underlying miR‐29‐OXPHOS complex pathways

MicroRNA-29a-c decrease fasting blood glucose levels by negatively regulating hepatic gluconeogenesis.

Pancreatic β cells control glucose homeostasis via the secretion of exosomal miR-29 family

MicroRNA-29 Fine-tunes the Expression of Key FOXA2-Activated Lipid Metabolism Genes and Is Dysregulated in Animal Models of Insulin Resistance and Diabetes

MicroRNA-29b Inhibits Diabetic Nephropathy in Db/db Mice.

Altered miR-29 Expression in Type 2 Diabetes Influences Glucose and Lipid Metabolism in Skeletal Muscle

Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes.

Mir-29A Negatively Affects Glucose-Stimulated Insulin Secretion and MIN6 Cell Proliferation Via Cdc42/β-Catenin Signaling

Expression of miRNA-29 in Pancreatic β Cells Promotes Inflammation and Diabetes via TRAF3

Pancreatic Cells Control Glucose Homeostasis Via the Secretion of Exosomal Mir-29 Family

MicroRNA‑29a is involved lipid metabolism dysfunction and insulin resistance in C2C12 myotubes by targeting PPARδ

MicroRNA-29 suppresses glucose uptake stimulated by insulin in L6 myotube cells

MicroRNA-26a Regulates Insulin Sensitivity and Metabolism of Glucose and Lipids.

MicroRNA-223 is Essential for Maintaining Functional Β-Cell Mass During Diabetes Through Inhibiting Both FOXO1 and SOX6 Pathways

MicroRNA-15a Positively Regulates Insulin Synthesis by Inhibiting Uncoupling Protein-2 Expression

Mir‐29 Contributes to Normal Endothelial Function and Can Restore It in Cardiometabolic Disorders

MicroRNA-29c Is a Signature MicroRNA under High Glucose Conditions That Targets Sprouty Homolog 1, and Its in Vivo Knockdown Prevents Progression of Diabetic Nephropathy*

[Mir-494-3p Reduces Insulin Sensitivity in Diabetic Cardiomyocytes by Down-Regulation of Insulin Receptor Substrate 1].

MicroRNA-27a/b Negatively Regulates Hepatic Gluconeogenesis by Targeting FOXO1.

Mir-29 Contributes To Normal Endothelial Function In Healthy Human Resistance Arterioles And Restores Endothelium-Dependent Vasodilation In Type 2 Diabetes

MicroRNA-27b-3p regulates function and metabolism in insulin resistance cells by inhibiting receptor tyrosine kinase-like orphan receptor 1